Amarillo Globe-News on MSN16h
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patients
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
News Medical on MSN5d
The impact of fall-risk medications on injuries in COPD patients
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Commonly prescribed medications can increase fall risk and related injuries in people with COPD
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Hosted on MSN2mon
Promising results for COPD treatment: Researchers find form of vitamin B3 reduces lung inflammation
COPD patients often experience shortness of breath ... to people suffering from this difficult disease," he says. More information: Kristoffer L. Norheim et al, Effect of nicotinamide riboside ...
Expanded research on COPD and metabolic syndrome would advance patient-centered care, expert argues
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
The Pharma Letter3d
AstraZeneca's Fasenra set to revolutionize COPD treatment
UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...
Researchers discover how cigarette smoke impairs critical lung immune cells
Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory ...
Medscape4d
High Dose N--Acetylcysteine in Patients With Exacerbations of Chronic Obstructive Pulmonary Disease
Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).
Monthly Prescribing Reference14d
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...
Business Insider12d
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
COPD, which affects millions of patients worldwide, has seen very limited treatment ... whether as a result of new information, future events or otherwise.
EurekAlert!12d
Expanded research on COPD and metabolic syndrome would advance patient-centered care
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.